Pancreatic Cancer Research

ResearcherNebraska Medical CenterNo recent work listed

Christopher M. Thompson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-6284-1919; OpenAlex author ID A5005328949; NIH RePORTER profile ID 14844711. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
32
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 2 papers, 1 grant · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 8

  1. Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis. Co-author DOI 10.1038/s41388-022-02587-1↗
  2. Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance. Co-author DOI 10.1053/j.gastro.2021.09.017↗
  3. Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00535-021-01800-4↗
  4. Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-21-1591↗
  5. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41416-020-0772-3↗
  6. CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma. First author DOI 10.1158/1078-0432.ccr-20-1359↗
  7. Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition. Co-author DOI 10.1016/j.trsl.2018.12.008↗
  8. Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. First author DOI 10.18632/genesandcancer.171↗

Grants 1

  1. Mucin Splice Variants in Pancreatic Cancer Diagnosis and Pathogenesis F31CA243469↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 6 shared papers, 2018–2023 · strength 0.76
  2. Sushil Kumar K · 6 shared papers, 2018–2023 · strength 0.74
  3. Rakesh Bhatia · 5 shared papers, 2020–2023 · strength 0.66
  4. Andrew C. Cannon · 5 shared papers, 2018–2023 · strength 0.63
  5. Pranita Atri · 3 shared papers, 2020–2022 · strength 0.36
  6. Satyanarayana Rachagani · 3 shared papers, 2019–2023 · strength 0.35
  7. Koelina Ganguly · 2 shared papers, 2022–2023 · strength 0.28
  8. Jesse L. Cox · 2 shared papers, 2022–2023 · strength 0.28
  9. Maneesh Jain · 2 shared papers, 2018–2023 · strength 0.25
  10. Sushil Kumar · 2 shared papers, 2019–2021 · strength 0.22
  11. H. Carlo Maurer · 2 shared papers, 2019–2020 · strength 0.20
  12. Kenneth P. Olive · 2 shared papers, 2019–2020 · strength 0.20
  13. Naveenkumar Perumal · 1 shared paper, 2023 · strength 0.15
  14. Xiaoqi Li · 1 shared paper, 2023 · strength 0.15
  15. Joyce C. Solheim · 1 shared paper, 2021 · strength 0.15
  16. Sanchita Rauth · 1 shared paper, 2022 · strength 0.13
  17. Sukhwinder Kaur · 1 shared paper, 2022 · strength 0.13
  18. Kavita B. Mallya · 1 shared paper, 2022 · strength 0.13
  19. Lynette M. Smith · 1 shared paper, 2021 · strength 0.12
  20. Saswati Karmakar · 1 shared paper, 2020 · strength 0.11
  21. Frank Leon · 1 shared paper, 2020 · strength 0.11
  22. Rohitesh Gupta · 1 shared paper, 2020 · strength 0.11
  23. Dipakkumar R. Prajapati · 1 shared paper, 2020 · strength 0.11
  24. Palanisamy Nallasamy · 1 shared paper, 2020 · strength 0.11
  25. Seema Chugh · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.